Thanks to @leukaemiauk.bsky.social for helping to make it happen!
05.03.2026 18:21 — 👍 2 🔁 1 💬 0 📌 0Thanks to @leukaemiauk.bsky.social for helping to make it happen!
05.03.2026 18:21 — 👍 2 🔁 1 💬 0 📌 0
A graphic with icons of Big Ben and a hand holding a megaphone. The text reads, ‘Fantastic news! Rare Cancers Bill passes Third Reading in House of Lords’ with the Leukaemia UK logo.
We were pleased to see The Rare Cancers Bill pass the Third Reading in the House of Lords last week.
The Bill will help those with leukaemia and other rare cancers benefit from research, clinical trials and new treatments. Thank you @drscottarthurmp.bsky.social for bringing it to the House.
Two women, a patient and a nurse, are looking at each other and smiling. The nurse has her hand on top of the patient’s hand, in a comforting way. The text reads, ‘Are you a healthcare professional? Could your project idea help to improve treatment, care, and quality of life for leukaemia patients?’
We’re delighted to announce further funding for healthcare professionals to undertake projects to improve treatment, care and quality of life for leukaemia patients. 🧡
Applications for our Patient Care Pioneer Award are now open.
Find out more & apply: www.leukaemiauk.org.uk/research-and...
Have you ever heard of Graft-versus-host disease (GvHD) - a complication that can happen after a stem cell transplant?
In our latest blog, we explore how and why it happens, how transplant teams try to reduce the risk, and how it can be treated. 👇
www.leukaemiauk.org.uk/stories/when...
Thank you @douglasmcallister.bsky.social for raising the issues of delays in diagnosing leukaemia. We are glad that @rthonwesstreeting.bsky.social recognises the issue and we're ready to work with the Government to ensure that the National Cancer Plan delivers for those affected by leukaemia.
25.02.2026 14:19 — 👍 2 🔁 1 💬 0 📌 0
🧬The Labour Government's National Cancer Plan will address unacceptable delays in leukaemia diagnoses, with 1/4 patients facing avoidable delays in being diagnosed.
I asked the Minister how this will be implemented, with the historic introduction of genomic testing at birth.
@leukaemiauk.bsky.social
An orange graphic with icons of Cardiff castle and the flag of Wales. The text reads, ‘Our vision for Wales’ and ‘Driving real, meaningful change for those affected by leukaemia in Wales.’
Leukaemia patients in Wales face significant gaps in diagnosis, treatment and care. 🏴⚠️
The next Senedd MUST represent a moment of real change. We’re ready to work with the Welsh Government to stop leukaemia devastating lives.
Read our report for Wales here: www.leukaemiauk.org.uk/app/uploads/...
An orange graphic with icons of the flag of Scotland, and a man wearing a kilt and playing the bagpipes. The text reads, ‘Our vision for Scotland’ and ‘Together, we can turn ambition into progress for people with leukaemia in Scotland.’
Scotland has the power to transform the future for people with leukaemia. We're ready to work with the Scottish Government to turn the ambitious vision of the Scottish Cancer Strategy into progress for leukaemia patients. 🏴
Read our report for Scotland here: www.leukaemiauk.org.uk/app/uploads/...
What does the Government’s new National Cancer Plan mean for people with leukaemia?
In our latest blog, we take an in-depth look at the commitments that could transform diagnosis, treatment and care for leukaemia patients. 👇
www.leukaemiauk.org.uk/news/nationa...
Today’s National Cancer Plan marks a major breakthrough in improving early diagnosis for leukaemia, with a new metric aiming to reduce the number of cancers diagnosed in an emergency setting – something we have campaigned for relentlessly. This is a major step forward for people with leukaemia and a huge testament to the strength of our community’s voices. We are now ready to work with Government to ensure this plan will deliver earlier diagnosis, improved survival and better quality of life for the thousands of people diagnosed with leukaemia every year. Together, we will stop leukaemia devastating lives. Fiona Hazell, Leukaemia UK CEO
📢 A huge win for #WorldCancerDay!
The Government has announced a new metric to track early diagnosis for leukaemia, as part of the National Cancer Plan.
We’ve campaigned for this commitment & will work to ensure it delivers for leukaemia patients. 🧡
With the National Cancer Plan set to be published tomorrow, our CEO Fiona Hazell sets out why the Government must urgently commit to earlier diagnosis targets for leukaemia - to improve outcomes and to save lives
healthcaretoday.com/article/comm...
This week, the Government will launch its National Cancer Plan for England.
We’re keeping you updated with the latest developments - including a £200m investment in local cancer care and greater access to trials for rare cancer patients - and our response. www.leukaemiauk.org.uk/news/latest-...
Red blood cells in the bloodstream. The text on top of the image reads, ‘Researchers develop new drug which could lead to more effective, targeted treatments for AML’ with the Leukaemia UK logo.
Could blocking a specific signalling pathway weaken AML cells and pave the way for new targeted treatments?
Researchers have developed a drug designed to block key proteins found in Interleukin-1 (IL-1) - a signalling pathway relied upon by AML cells.
🔗 medicine.iu.edu/news/2026/01...
@houseoflords.parliament.uk
20.01.2026 11:25 — 👍 0 🔁 0 💬 0 📌 0It was great to see the Rare Cancers Bill pass its Second Reading in the House of Lords last week. Thank you to Baroness Delyth Morgan for speaking about the poor survival rates for AML and raising the issues in leukaemia that the bill hopes to address. 🤞
20.01.2026 11:25 — 👍 3 🔁 0 💬 1 📌 0
Dr Matthew Blunt, one of Leukaemia UK’s John Goldman Fellows and follow-up fund recipients. The text reads, ‘New paper: Leukaemia research reveals findings which could help to treat autoimmune diseases’ with the Leukaemia UK logo.
Congrats to Dr Matthew Blunt & team on their latest publication, revealing findings which could help to treat autoimmune disease. 👏
A great example of how discoveries in blood cancer research can drive progress across other areas of medicine! ✨
academic.oup.com/cei/advance-...
We’re thrilled to hear that patients are already receiving Aucatzyl, a novel CAR-T therapy for B-ALL, less than a month after it was approved for use on the NHS.
We’re proud to have advocated for its approval with @anthonynolan.bsky.social @leukaemiacare.bsky.social 🧡
www.bbc.co.uk/news/article...
Just incredible! Did you know that umbilical cord blood is rich in stem cells, and can be used for stem cell transplants - a crucial treatment option for many leukaemia patients? 🩸
www.bbc.co.uk/news/article...
An image of red blood cells in the bloodstream. The text reads, ‘New study brings us a step closer to understanding infant leukaemia - and why it is so difficult to treat’.
A fascinating study by our co-funded researcher, Dr Katrin Ottersbach @edinburgh-uni.bsky.social, brings us closer to understanding why infant leukaemia is so hard to treat - and how future therapies might better target the disease.
🔗 www.exphem.org/article/S030...
An orange graphic which reads, ‘New treatment for chronic lymphocytic leukaemia in England: Venetoclax with obinutuzumab’ followed by ‘Approved’ with a green tick symbol.
A fantastic start to the year! Venetoclax with obinutuzumab has been approved on the NHS in England for people with untreated CLL, expanding access to a fixed-duration, targeted first-line treatment option. 👏
08.01.2026 11:32 — 👍 0 🔁 0 💬 0 📌 0
Three people are sat around a table in an office. They are pointing to a piece of paper and smiling. In the background, on the wall, the writing reads, ‘Discoveries happen all the time’. The text on the image reads, ‘We’re hiring! Research Manager'.
Are you enthusiastic about research and its potential to improve our understanding of leukaemia, develop kinder treatments and enhance patient care?
Apply to be our next Research Manager 👉 www.leukaemiauk.org.uk/about-us/wor...
A conference hall with signs and exhibition stands. The entrance sign reads, ‘American Society of Hematology’.
📢 Gentler, smarter and more personalised therapies are reshaping the future of leukaemia treatment and care.
We took a deep dive into some of the key takeaways from this year’s American Society of Haematology (ASH) conference. 🩸 #ASH25 @ash.hematology.org
www.leukaemiauk.org.uk/stories/rese...
Last week, we shared the fantastic news about BE-CAR7 - a world-first therapy using CRISPR technology to treat T-cell leukaemia. 🔬
But what exactly is CRISPR? How is it different from standard CAR-T therapy? And why is it such a big deal? 👇
www.leukaemiauk.org.uk/stories/rese...
Dr Simon Ridley, Director of Research & Advocacy at Leukaemia UK, at the American Society of Hematology (ASH) conference in Orlando. He is standing in front of a red backdrop with the ASH logo.
Multiple screens showing the American Society of Hematology (ASH) logo on a red backdrop. A person is sitting behind a table on stage and there are silhouettes of several people with cameras.
It was a pleasure to attend @ash.hematology.org this week and learn about all of the promising advancements in leukaemia treatment and care - from gentler treatments for AML to next-gen CAR-T therapies.
Look out for our upcoming blog for a deeper dive! #ASH25 🩸
A major breakthrough! A world-first therapy - BE-CAR7 - is using base-edited immune cells to treat T-cell acute lymphoblastic leukaemia (T-ALL) - one of the most aggressive and hardest-to-treat types of leukaemia.
https://www.bbc.co.uk/news/articles/cj38ymeyg4mo
Two images of Leukaemia UK’s John Goldman Fellows for 2023 and 2024. The text reads, ‘Apply for our 2026 John Goldman Fellowships’.
We are delighted to announce further funding into ground-breaking research in 2026, by continuing our investment in early career scientists & clinicians!
📢 Applications for our 2026 John Goldman Fellowships are now open.
Find out more: www.leukaemiauk.org.uk/research-and...
An orange graphic which reads, ‘New drug for B-cell acute lymphoblastic leukaemia in England: Aucatzyl' followed by ‘Approved’ with a green tick symbol.
📢 A significant step forward in expanding treatment options for B-ALL.
We’re thrilled that Aucatzyl - a CAR-T cell therapy for treating relapsed or refractory B-cell acute lymphoblastic leukaemia - has been approved for use on the NHS in England.
www.leukaemiauk.org.uk/news/leukaem...
How incredible is this?! Huge congratulations and a big thank you to Shaun and Salim, who completed the world’s most dangerous dive to raise funds for life-changing leukaemia research in memory of their friend, Trish. 🧡👏
www.express.co.uk/news/uk/2135...
The recipient of our 2025 Patient Care Pioneer Award: Dr Sarah Stapleton 🏆
Dr Stapleton will look at the psychological support that leukaemia patients might need, and develop a framework to help guide healthcare professionals.
www.leukaemiauk.org.uk/research-and...
An image of a T-cell, a type of lymphocyte which plays a vital role in the body’s immune system. The text on the image reads, ‘Major study uncovers new subtype of T-cell ALL, which can be detected using routine tests at point of diagnosis’.
Major breakthrough for T-ALL! Researchers have identified a previously unknown subtype, which can be detected using routine tests. 👏
This means clinicians could soon pinpoint high-risk cases at diagnosis & personalise treatment for children with T-ALL.
bioengineer.org/breakthrough...
